Physician profile
Christopher Ellington
NPI 1154579605
$24,154.36
in general payments reported to CMS, 2019-2025
38 companies · $4,594 in 2025
The $4,594 reported for 2025 was more than what 81% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,682 · 2020: $7,078 · 2021: $1,000 · 2022: $2,661 · 2023: $1,944 · 2024: $2,195 · 2025: $4,594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,753 · Education: $3,000 · Travel and Lodging: $980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,753.12 |
| Education | $3,000.00 |
| Travel and Lodging | $980.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,311.83 | 2019-2025 | |
| Abbott Laboratories | $3,877.49 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Epic, 2nd Gen Centrimag Primary Console |
| Edwards Lifesciences Corporation | $3,087.26 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Inspiris Resilia Aortic Valve |
| Atricure, INC. | $2,364.51 | 2021-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Getinge USA Sales, LLC | $317.56 | 2020-2024 | Vasoview Hemopro 2, Cardioroot |
| Galvanize Therapeutics, INC | $283.53 | 2025 | Aliya System |
| Abiomed | $219.17 | 2024-2025 | |
| Clearflow INC. | $185.52 | 2019 | |
| Ethicon US, LLC | $147.17 | 2019-2023 | Prolene, Evarrest, Surgicel Nu-Knit |
| Baxter Healthcare | $124.87 | 2020-2024 | Perclot, Preveleak |
| Astrazeneca Pharmaceuticals LP | $96.16 | 2019-2025 | Imfinzi |
| Kls-Martin L.P. | $88.98 | 2025 | |
| Davol INC. | $88.75 | 2019-2024 | Progel Applicator Spray Tips |
| Lemaitre Vascular, INC. | $88.04 | 2020 | |
| Inari Medical, INC. | $72.70 | 2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $67.35 | 2021 | |
| Stryker Corporation | $63.39 | 2021-2024 | Spy-Phi System |
| Lsi Solutions INC | $61.23 | 2021-2024 | Cor-Knot, Cor Knot |
| Boston Scientific Corporation | $55.16 | 2023-2025 | General - Therapies, Varithena Administration Pack |
| E.R. Squibb & Sons, L.L.C. | $52.63 | 2022-2025 | Opdivo |
| Jazz Pharmaceuticals INC. | $48.44 | 2025 | |
| Merck Sharp & Dohme LLC | $46.18 | 2025 | Keytruda, Welireg, Reblozyl |
| Janssen Pharmaceuticals, INC | $44.86 | 2019-2022 | |
| Artivion, INC. | $41.46 | 2019-2020 | |
| Terumo Cardiovascular Systems Corporation | $40.95 | 2019 | |
| Medtronic Vascular, INC. | $32.69 | 2020 | |
| Hemosonics LLC | $28.64 | 2022 | |
| Depuy Synthes Sales INC. | $26.86 | 2020 | |
| Team 1, LLC | $24.59 | 2024 | |
| Incyte Corporation | $24.07 | 2025 | Jakafi |
| Olympus America INC. | $21.06 | 2022 | |
| Daiichi Sankyo INC. | $20.17 | 2025 | Enhertu |
| Ferring Pharmaceuticals INC. | $19.79 | 2022 | |
| Angiodynamics, INC. | $19.48 | 2022 | |
| Teleflex LLC | $17.17 | 2021 | |
| Haemonetics Corporation | $16.86 | 2024 | Teg5000 Hemostasis Analyzer |
| Genentech USA, INC. | $16.83 | 2025 | Polivy |
| Cook Medical LLC | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ellington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.